Objectives A meta-analysis was conducted to examine the effectiveness of HPV self-
sampling proposal on cervical cancer screening (CCS) uptake when compared with an …

In Southeast Asia, cervical cancer is the second most common cancer in women. Low
coverage for cervical cancer screening (CCS) becomes a roadblock to disease detection …

Background While the evidence for the clinical effectiveness of most noncommunicable
disease (NCD) prevention and treatment interventions is well established, care delivery …

Background: Cervical cancer is the fourth most common cancer in women, and it is well
known that high-risk human papillomavirus (hrHPV) infections are the necessary …

Background Screening for HPV has led to significant reductions in cervical cancer deaths in
high-income countries. However, the same results have not been achieved in low-and …

PURPOSE Although cervical cancer is a disease of inequity, it can be eliminated as a public
health problem through vaccination, screening, and treatment. Human papillomavirus …

Abstract Background In July 2022, self‐collection became universally available as part of
Australia's National Cervical Screening Program. This change aims to address screening …

Human Papillomavirus (HPV) self-sampling has been implemented successfully as an
alternative to traditional forms of cervical cancer screening in low-resource settings. Through …

Introduction HPV self-sampling is a relatively new, cost-effective and widely accepted
method, however, uptake in LMICs remains limited. We aimed to map out the evidence and …

Introduction: Like many countries in Sub-Saharan Africa, Cameroon has a high burden of
cervical cancer and low availability and uptake of screening. Self-collection has the potential …